Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Wasserman Building
300 Stein Plaza, Suite 420
Los Angeles, CA 90095Phone+1 310-825-5111
Summary
- Dr. Anthony Wang is a recognized leader and expert in bypass for moyamoya disease, complex pediatric brain tumors, complex skull base surgery, Chiari malformations, cavernous malformations, aneurysm and AVM surgery. He specializes in pediatric and adult cerebrovascular and tumor surgeries, and has trained many neurosurgeons throughout the United States in each of these subspecialties. Dr. Wang’s laboratory focuses on tailoring immunotherapy for pediatric brain tumors.
Clinical Expertise
- Neurosurgical oncology, Skull base surgery, Pediatric neurosurgery, Cerebrovascular disease, Minimally invasive neurosurgery
Education & Training
- University of WashingtonFellowship, Pediatric Neurosurgery, 2015 - 2016
- University of Miami/Jackson Health SystemFellowship, Cerebrovascular & Skull Base Surgery, 2014 - 2015
- University of MichiganResidency, Neurological Surgery, 2007 - 2014
- Duke University School of MedicineClass of 2007
- Vanderbilt UniversityBS, Neurobiology, Magna Cum Laude, 1999 - 2003
Certifications & Licensure
- CA State Medical License 2016 - 2025
- NV State Medical License 2017 - 2025
- WA State Medical License 2015 - 2017
- MI State Medical License 2007 - 2016
- American Board of Neurological Surgery Neurological Surgery
- American Board of Pediatric Neurological Surgery Pediatric Neurological Surgery
Awards, Honors, & Recognition
- U.S. Presidential Scholar United States Congress
Clinical Trials
- Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant Start of enrollment: 2024 Dec 01
Roles: Principal Investigator, Contact
- The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 Start of enrollment: 2022 Mar 17
- MIND: Artemis in the Removal of Intracerebral Hemorrhage Start of enrollment: 2018 Feb 07
Publications & Presentations
PubMed
- 13 citationsExtent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis.Rami Hatoum, Jia-Shu Chen, Pascal Lavergne, Nathan A Shlobin, Andrew Wang
JAMA Network Open. 2022-08-01 - 12 citationsPrecision Medicine in Pediatric Neurooncology: A Review.Aaron Mochizuki, Isaura M. Frost, Melina B. Mastrodimos, Ashley Plant, Anthony C. Wang
ACS Chemical Neuroscience. 2018-01-17 - 5 citationsMutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor.Bingcheng Jiang, Cameron Murray, Bonnie L Cole, J N Mark Glover, Gordon K Chan
Scientific Reports. 2022-03-30
Journal Articles
- Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 MutationsAria Fallah, Chibawanye Ene, Jeffrey G Ojemann, Anthony C Wang, Amy Lee, Clinical Cancer Research
Authored Content
- Atypical Presentation of Giant Aneurysm in a Pediatric Patient with Duane SyndromeMay 2018
Press Mentions
- Here's Why Joni Mitchell's Performance at the Newport Folk Festival Is so IncredibleJuly 26th, 2022
- Scariest Moment of My LifeApril 22nd, 2022
- A Battle for My LifeMarch 1st, 2019
- Join now to see all
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: